Rev up 9%
Operating expenses up 40.5%
Net profit down 22%
Net flows for the year were 8 billion, not the 17b last year but given market conditions this isn't necessarily a bad result.
They broke it down nicely in the graph below
Balance sheet remains very strong.
Interesting that they have closed their EM strategy to new investors, not sure if I missed that announcement or if it is new news.
Would like to hear others thoughts on this result,
Cheers,
Plague.
- Forums
- ASX - By Stock
- GQG
- Ann: 2022 Full Year Results - Investor Presentation
GQG
gqg partners inc.
Add to My Watchlist
0.21%
!
$2.33

Ann: 2022 Full Year Results - Investor Presentation, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.33 |
Change
-0.005(0.21%) |
Mkt cap ! $6.871B |
Open | High | Low | Value | Volume |
$2.30 | $2.34 | $2.29 | $934.1K | 403.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 10146 | $2.32 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.33 | 30152 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 10046 | 2.320 |
10 | 12390 | 2.310 |
9 | 10603 | 2.300 |
12 | 33334 | 2.290 |
2 | 4518 | 2.280 |
Price($) | Vol. | No. |
---|---|---|
2.330 | 30036 | 14 |
2.340 | 32797 | 16 |
2.350 | 85692 | 9 |
2.360 | 53150 | 4 |
2.370 | 15605 | 6 |
Last trade - 11.46am 04/07/2025 (20 minute delay) ? |
Featured News
GQG (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online